The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Originally identified in Drosophila melanogaster, the Warts(Wts)/Lats protein kinase has been proposed to function with two other Drosophila proteins, Hippo (Hpo) and Salvador (Sav), in the regulation of cell cycle exit and apoptosis. In mammals, two candidate Warts/Lats homologs, termed Lats1 and Lats2, have been described, and the targeted disruption of LATS1 in mice increases tumor formation. Little, however, is known about the function and regulation of human Lats kinases. Here we report that human Mst2, a STE20-family member and purported Hpo ortholog, phosphorylates and activates both Lats1 and Lats2. Deletion analysis revealed that regulation of Lats1 occurs through the C-terminal, catalytic domain. Within this domain, two regulatory phosphorylation sites were identified by mass spectrometry. These sites, S909 in the activation loop and T1079 within a hydrophobic motif, have been highly conserved during evolution. Moreover, a direct interaction was observed between Mst2 and hWW45, a putative ortholog of Drosophila Sav. These results indicate that Mst2-like kinases regulate Lats kinase activities in an evolutionarily conserved regulatory pathway. Although the function of this pathway remains poorly understood in mammals, it is intriguing that, in Drosophila, it has been linked to development and tissue homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, LATS1 requires phosphorylation to be active [105] and LATS1 phosphorylation was increased on the non-acetylated, less stable LATS1K751R [104].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [105]
Citations
Cites
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Genomic Libraries and a Host Strain Designed for Highly Efficient Two-Hybrid Selection in Yeast
James, P., Halladay, J., & Craig, E. A. (1996) · Genetics · doi:10.1093/genetics/144.4.1425 · Cited by 2,637
Active and Inactive Protein Kinases: Structural Basis for Regulation
Johnson, L. N., Noble, M. E. M., & Owen, D. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81092-2 · Cited by 1,403 · cited 2×
“Interestingly, these sites are located within the activation loop (S909) and a hydrophobic motif (T1079), two domains previously been implicated in the activation of other kinases (Johnson et al., 1996; Tamaskovic et al., 2003).”
Okadaic acid: a new probe for the study of cellular regulation
Cohen, P., Holmes, C. F. B., & Tsukitani, Y. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90192-e · Cited by 1,387
Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098 · cited 10×
“When expressed in Drosophila, Mst2 was able to rescue the hpomutant phenotype, showing that it can act as a functional ortholog (Wu et al., 2003).”
BackgroundResultInfluentialDammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Justice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes & Development · doi:10.1101/gad.9.5.534 · Cited by 977
The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis
Harvey, K. F., Pfleger, C. M., & Hariharan, I. K. (2003) · Cell · doi:10.1016/s0092-8674(03)00557-9 · Cited by 976 · cited 7×
“These data suggested that Wts/Lats, Sav and Hpo might form a trimeric complex in which Sav functions as an adaptor protein to bring Wts/Lats in close proximity to Hpo (Harvey et al., 2003).”
BackgroundResultInfluentialTapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Haber, D. A., & Hariharan, I. K. (2002) · Cell · doi:10.1016/s0092-8674(02)00824-3 · Cited by 856 · cited 7×
“…neither the N-terminally located putative UBA domain, a structure believed to bind ubiquitin moieties (Buchberger, 2002), nor the PPXY motifs, previously implicated in mediating the interaction between Wts/lats and Sav in Drosophila (Tapon et al., 2002), were required for this regulation.”
BackgroundResultInfluentialXu, T., Wang, W., Zhang, S., Stewart, R. A., & Yu, W. (1995) · Development · doi:10.1242/dev.121.4.1053 · Cited by 799
Cited by
Items 301–400 of 604
Disease implication of hyper-Hippo signalling
Wang, S., & Wang, L.-H. (2016) · Open Biology · doi:10.1098/rsob.160119 · Cited by 33
Mob Family Proteins: Regulatory Partners in Hippo and Hippo-Like Intracellular Signaling Pathways
Duhart, J. C., & Raftery, L. A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00161 · Cited by 33
Ca2+ signaling and the Hippo pathway: Intersections in cellular regulation
Sayedyahossein, S., Thines, L., & Sacks, D. B. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110846 · Cited by 34
Chang, Y., Fu, X., Cui, M., Li, W., Zhang, L., Li, X., Li, L., Sun, Z., Zhang, X., Li, Z., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2174 · Cited by 35
Type I collagen inhibits adipogenic differentiation via YAP activation in vitro
Liu, X., Long, X., Gao, Y., Liu, W., Hayashi, T., Mizuno, K., Hattori, S., Fujisaki, H., Ogura, T., Onodera, S., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29100 · Cited by 34
“YAP is regulated by skeletal ECM proteins through cytoskeletal structures (Chan et al., 2005; Piccolo et al., 2014).”
BackgroundThe Regulatory Role of KIBRA and PTPN14 in Hippo Signaling and Beyond
Wilson, K. E., Yang, N., Mussell, A. L., & Zhang, J. (2016) · Genes · doi:10.3390/genes7060023 · Cited by 37
“In mammals, the main proteins that are known to directly phosphorylate YAP/TAZ are the large tumor suppressor kinases 1 and 2 (LATS1/2) [1–4].”
BackgroundMechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis
Zhang, J., Zhou, Y., Tang, P. M., Cheng, A. S. L., Yu, J. Q., To, K. F., & Kang, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071576 · Cited by 32
“Mammalian Hippo signaling pathway is evolutionarily conserved and composed of several kinases, mammalian Ste20-like kinases 1 and 2 (MST1/2), and Large tumor suppressor kinase 1 and 2 (LATS1/2) [17].”
BackgroundCai, Z., Guldbrandtsen, B., Lund, M. S., & Sahana, G. (2019) · BMC Genetics · doi:10.1186/s12863-019-0717-0 · Cited by 35
Lee, H., Kang, J., Ahn, S., & Lee, J. (2019) · Genetics · doi:10.1534/genetics.119.302477 · Cited by 36
Yeo, M., Kim, S., Kim, J., Huang, S., Kim, M., Song, K. S., & Kim, K. (2012) · Anticancer Research · Cited by 33
Mutual regulation of the Hippo/Wnt/LPA/TGF‑β signaling pathways and their roles in glaucoma (Review)
Wang, X., Huai, G., Wang, H., Liu, Y., Qi, P., Shi, W. Q., Peng, J., Yang, H., Deng, S., & Wang, Y. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3352 · Cited by 38
The Regulation of the Hippo Pathway by Intercellular Junction Proteins
Ahmad, U. S., Uttagomol, J., & Wan, H. (2022) · Life · doi:10.3390/life12111792 · Cited by 38
“In addition, phosphorylation of MOB1A/B leads to its affinity and interaction with LATS1/2, causing a cascade of autophosphorylation of this protein within the activation loop [24,25].”
BackgroundMammalian Ste20-Like Kinase and SAV1 Promote 3T3-L1 Adipocyte Differentiation by Activation of PPARγ
Park, B. H., Kim, D. S., Won, G. W., Jeon, H. J., Oh, B., Lee, Y., Kim, E., & Lee, Y. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030983 · Cited by 35
“Studies in Drosophila and mammalian systems have reported that SAV1 recruits LATS to MST to promote the phosphorylation of LATS by MST [8,9] and that SAV1 is required for the correct cellular localization and function of MST [10].”
BackgroundHippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis
Azad, T., Rezaei, R., Surendran, A., Singaravelu, R., Boulton, S., Dave, J., Bell, J. C., & Ilkow, C. S. (2020) · Cancers · doi:10.3390/cancers12082042 · Cited by 32
“It then phosphorylates LATS1/2 while connected to MOB1A/B [11].”
BackgroundZhou, R., Wu, Q., Wang, M., Irani, S., Li, X., Zhang, Q. Y., Meng, F., Liu, S., Zhang, F., Wu, L., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001122 · Cited by 30
“Intriguingly, PPM1A was able to reverse the YAP transcriptional potential that was stimulated by a phosphomimetic LATS1 mutant (T1079D) [42] (Fig 3B and 3C), suggesting that PPM1A may directly target YAP/TAZ.”
BackgroundYAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming
Benedetto, G. D., Parisi, S., Russo, T., & Passaro, F. (2021) · Metabolites · doi:10.3390/metabo11030154 · Cited by 32
“Subsequently, LATS1/2 undergoes autophosphorylation and activation [28].”
Dvash, E., Kra‐Oz, G., Ziv, C., Carmeli, S., & Yarden, O. (2009) · Eukaryotic Cell · doi:10.1128/ec.00230-09 · Cited by 31
“This protein can associate with both Hippo pathway components (e.g., MOB1 and STE20 [6, 27, 34]), while it has also been shown to associate with CCR4, which is also involved in glycogen metabolism (via a transcriptional activator intermediate, identified in yeasts as MSN2/4 [30, 56]), or, possibly, by inhibition of CD…”
ResultInfluentialAmanda, B., Pragasta, R., Cakrasana, H., Mustika, A., Faizah, Z., & Oceandy, D. (2024) · Cells · doi:10.3390/cells13221868 · Cited by 28
Chen, H., Li, Q., Nirala, N. K., & Ip, Y. T. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.03.021 · Cited by 29
Regulation and functions of the Hippo pathway in stemness and differentiation
Cao, X., Wang, C., Liu, J., & Zhao, B. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa048 · Cited by 32
Role of Hippo-YAP1/TAZ pathway and its crosstalk in cardiac biology
Chen, X., Yuan, W., Li, Y., Luo, J., & Hou, N. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47142 · Cited by 31
Optogenetic control of YAP cellular localisation and function
Toh, P. J. Y., Lai, J. K. H., Hermann, A., Destaing, O., Sheetz, M. P., Sudol, M., & Saunders, T. E. (2022) · EMBO Reports · doi:10.15252/embr.202154401 · Cited by 29
Nagasawa‐Masuda, A., & Terai, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174633 · Cited by 32
Vitulo, N., Vezzi, A., Galla, G., Citterio, S., Marino, G., Ruperti, B., Zermiani, M., Albertini, E., Valle, G., & Barcaccia, G. (2007) · Evolutionary Bioinformatics · doi:10.1177/117693430700300007 · Cited by 33
“Human mammalian sterile 20-like kinase (MST1/2) associates with hWW45 (the human ortholog of Sav) and activates LATS1/2 by phosphorylation (Chan et al. 2005).”
BackgroundTargeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer
Truong, D. D., Lamhamedi-Cherradi, S.-E., & Ludwig, J. A. (2022) · Journal of bone oncology · doi:10.1016/j.jbo.2022.100419 · Cited by 26
“the cytosolic YAP/TAZ and afterward boosted nuclear YAP[180].”
BackgroundYan, G., Qin, Q., Yi, B., Chuprun, K. J., Sun, H., Huang, S., & Sun, J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.045 · Cited by 28
“In addition to Histone H2B, several Mst1 substrates, including FOXO [7] [8] [9], LATS1/2 [10] [11], JNK [12] and cardiac troponin I [13], have been recently identified.”
BackgroundHan, Y., Tang, Z., Zhao, Y., Li, Q., & Wang, E. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22740 · Cited by 29
“The phosphorylation cascades of Hippo core components (MST1/2, SAV1, LATS1/2, and MOB1) inhibit the activation of transcriptional coactivators YAP and TAZ.(4) YAP and TAZ are major effectors of the Hippo signaling pathway.”
BackgroundThe STK38–XPO1 axis, a new actor in physiology and cancer
Martin, A. P. J., Aushev, V. N., Zalcman, G., & Camonis, J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03690-w · Cited by 28
Sun, X. K., Niu, X., Qin, N., Shan, X., Zhao, J., Ma, C., Xu, R., & Mishra, B. (2021) · Poultry Science · doi:10.1016/j.psj.2021.101454 · Cited by 25
Lv, H., & Ai, D. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.09.007 · Cited by 27
Xiao, Y., Liu, Q., Peng, N., Li, Y., Qiu, D., Yang, T., Kang, R. D., Usmani, A., Amadasu, E., Borlongan, C. V., et al. (2022) · Cell Transplantation · doi:10.1177/09636897221075749 · Cited by 25
RetractedHoward, A., Bojko, J., Flynn, B. P., Bowen, S., Jungwirth, U., & Walko, G. (2022) · Experimental Dermatology · doi:10.1111/exd.14655 · Cited by 29
MST1/2: Important regulators of Hippo pathway in immune system associated diseases
Zhou, J., Li, L., Wu, B., Feng, Z., Lu, Y., & Wang, Z. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216736 · Cited by 26
He, J., Tang, F., Liu, L., Chen, L., Li, J., Ou, D., Zhang, L., Li, Z., Feng, D., Li, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13775 · Cited by 28
“In mammalian tissue culture, Yap and TAZ activity and subcellular localization was regulated by changes in cell morphology and the actin cytoskeleton [23–25].”
BackgroundSTK3/4 Expression Is Regulated in Uterine Endometrial Cells during the Estrous Cycle
Moon, S., Lee, O., Lee, S., Lee, J., Park, H., Park, M., Chang, E. M., Park, K.-H., & Choi, Y. (2019) · Cells · doi:10.3390/cells8121643 · Cited by 25
“The pSTK3/4 immediately phosphorylates LATS1/2 resulting in the Hippo signaling activation [13].”
BackgroundConstantinescu-Aruxandei, D., Makbul, C., Koturenkiene, A., Lüdemann, M.-B., & Herrmann, C. (2011) · Biochemistry · doi:10.1021/bi201110h · Cited by 30
Yang, S., Xu, W., Liu, C., Jin, J., Li, X., Jiang, Y., Zhang, L., Meng, X., Zhan, J., & Zhang, H. (2022) · Science China Life Sciences · doi:10.1007/s11427-020-1914-3 · Cited by 24
Wnt/β-Catenin Signaling Regulates Yap/Taz Activity during Embryonic Development in Zebrafish
Astone, M., Tesoriero, C., Schiavone, M., Facchinello, N., Tiso, N., Argenton, F., & Vettori, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810005 · Cited by 28
Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges
Kumar, A., BharathwajChetty, B., Manickasamy, M. K., Unnikrishnan, J., Alqahtani, M. S., Abbas, M., Almubarak, H. A., Sethi, G., & Kunnumakkara, A. B. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107167 · Cited by 27
Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer
Nguyen, T., & Kugler, J. (2018) · Cancers · doi:10.3390/cancers10040121 · Cited by 26
“The core mammalian Hippo pathway comprises a cassette of the upstream “mammalian Ste20-like kinases 1 and 2” (MST1/2) and the downstream “large tumor suppressors 1 and 2” (LATS1/2).”
BackgroundInfluentialThe role of Hippo‐YAP/TAZ signaling in brain development
Terry, B. K., & Kim, S. (2022) · Developmental Dynamics · doi:10.1002/dvdy.504 · Cited by 27
Signaling Pathways in Inflammation and Cardiovascular Diseases: An Update of Therapeutic Strategies
Cucu, I. (2022) · Immuno · doi:10.3390/immuno2040039 · Cited by 24
Transcriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice
Siam, R., Harada, R., Cadieux, C., Battat, R. J., Vadnais, C., & Nepveu, A. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-60 · Cited by 26
“Mammals share a similar pathway whereby the Mst2/ WW45 phosphorylates LATS1 [15], and the LATS1/Mob1 complex phosphorylates YAP1 to keep it in the cytoplasm [13,16].”
BackgroundXiong, S., Lorenzen, K., Couzens, A. L., Templeton, C. M., Rajendran, D., Mao, D. Y. L., Juang, Y.-C. A., Chiovitti, D., Kurinov, I. V., Guettler, S., et al. (2018) · Structure · doi:10.1016/j.str.2018.05.014 · Cited by 24
“Regulation of NDR family catalytic function is mediated minimally at three key core levels: firstly by binding of MOB1 to the MBD (Hergovich et al., 2006), secondly by auto-phosphorylation on sites within the atypically long activation segment in the kinase domain (Ser281/282 in NDR1/2; Ser909/872 in LATS1/2; Chan et…”
BackgroundInfluentialYAP/TAZ: a promising target for squamous cell carcinoma treatment
Dong, X., Meng, L., Liu, P., Ji, R., Su, X., Xin, Y., & Jiang, X. M. (2019) · Cancer Management and Research · doi:10.2147/cmar.s197921 · Cited by 26
The Hippo pathway: Horizons for innovative treatments of peripheral nerve diseases
Feltri, M. L., Weaver, M. R., Belin, S., & Poitelon, Y. (2021) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12431 · Cited by 24
Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells
Wei, X., Ye, J., Shang, Y., Chen, H., Liu, S., Liu, L., & Wang, R. (2017) · Oncotarget · doi:10.18632/oncotarget.22673 · Cited by 23
Bao, Y., Sumita, K., Kudo, T., Withanage, K., Nakagawa, K., Ikeda, M., Ohno, K., Wang, Y., & Hata, Y. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2009.01354.x · Cited by 22
“There is another report that LATS1 T1079D mutant, which corresponds to LATS2 T1041D, is inactive by itself but is activated by MST2 (Chan et al. 2005).”
BackgroundInfluentialExpression of Hippo signaling pathway and Aurora kinase genes in chronic myeloid leukemia
Marsola, A. P. Z. C., Simões, B. P., Palma, L. C., Berzoti-Coelho, M. G., Burin, S. M., & de Castro, F. A. (2018) · Medical Oncology · doi:10.1007/s12032-018-1079-6 · Cited by 23
The spectraplakin Dystonin antagonizes YAP activity and suppresses tumourigenesis
Jain, P. B., Guerreiro, P. S., Canato, S., & Janody, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-56296-z · Cited by 22
Hippo signaling in regeneration and aging
Elster, D., & von Eyß, B. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111280 · Cited by 23
MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway
Lu, J., Hu, Z., Deng, Y., Wu, Q., Wu, M., & Song, H. X. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100400 · Cited by 25
Liang, F., Shi, L., Zheng, J., Chen, S., Wang, Y., & Zhang, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-08196-3 · Cited by 22
Pinelli, M., Makdissi, S., Scur, M., Parsons, B., Baker, K., Otley, A. R., MacIntyre, B., Nguyen, H. D., Kim, P. K., Stadnyk, A. W., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06925-x · Cited by 22
“The mammalian core kinases of the Hippo pathway consist of MST1/2 (ortholog of Drosophila Hippo/Hpo) [64], SAV1 (Salvador ortholog), LATS1/2 (Warts/Wts ortholog), and MOB1A/B (Mats ortholog).”
BackgroundZiv, C., Feldman, D., Aharoni‐Kats, L., Chen, S., Liu, Y., & Yarden, O. (2013) · Molecular Microbiology · doi:10.1111/mmi.12371 · Cited by 21
“(2005) have identified three phosphorylated Ser residues at the NTR of human LATS1 and at least one of them has been shown to be autophosphorylated (Chan et al., 2005).”
BackgroundStructural Insights into the Regulation of Hippo Signaling
Cairns, L. S., Tran, T. T., & Kavran, J. M. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01058 · Cited by 21
Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer
Lim, S. K., Tabatabaeian, H., Lu, S. Y., Kang, S., Sundaram, G. M., Sampath, P., Chan, S. W., Hong, W. J., & Lim, Y. P. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02901-3 · Cited by 21
Song, Y., Pan, S., Li, K., Chen, X., Wang, Z. P., & Zhu, X. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.001 · Cited by 25
Strepkos, D., Markouli, M., Papavassiliou, K. A., Papavassiliou, A. G., & Piperi, C. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12762 · Cited by 23
Phosphorylation of SAV1 by mammalian ste20-like kinase promotes cell death
Park, B. H., & Lee, Y. H. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.9.584 · Cited by 21
“ated phosphorylation of LATS (15, 16) and that SAV1 is required for the correct cellular localization and function of MST (17).”
BackgroundInfluentialAcetylation: a new target for protein degradation in cancer
Crawford, C. E. W., & Burslem, G. M. (2025) · Trends in Cancer · doi:10.1016/j.trecan.2025.01.013 · Cited by 20
Stepan, J., Heinz, D. E., Dethloff, F., Wiechmann, S., Martinelli, S., Hafner, K., Ebert, T., Junglas, E., Häusl, A. S., Pöhlmann, M. L., et al. (2024) · Science Signaling · doi:10.1126/scisignal.adj6603 · Cited by 20
“To interfere with LATS1/2 phosphorylation in vivo, we blocked the upstream kinases MST1 and MST2 (MST1/2) ( 30 ) with the small-molecule inhibitor XMU-MP1 (hereafter, MSTi) ( 31 – 33 ).”
Cell differentiation-related signaling pathways in hepatocellular carcinoma metastasis
Xiang, Z., Li, J., Xu, Y., Xu, C., Zheng, S., Chen, J., Wei, X., & Xu, X. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217846 · Cited by 21
Zhou, W., Lei, B., Yang, C., Silva, M., Xing, X., Yu, H., Lu, J., & Zheng, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065259 · Cited by 23
You, B., Huang, S., Qin, Q., Yi, B., Yuan, Y., Xu, Z., & Sun, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058697 · Cited by 22
“In addition to Histone H2B, several Mst1 substrates, including FOXO [7–9], LATS1/2 [10,11], JNK [12] and cardiac troponin I [13], have been recently identified.”
BackgroundKhanal, P., Yeung, B., Zhao, Y., & Yang, X. (2019) · Scientific Reports · doi:10.1038/s41598-019-42767-w · Cited by 24
YAP/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathways
Zhu, T., Ma, Z., Wang, H., Jia, X., Wu, Y., Fu, L., Li, Z., Zhang, C., & Yu, G. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03866-9 · Cited by 23
Kim, G., Bhattarai, P. Y., Lim, S., Kim, J. Y., & Choi, H. S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.033 · Cited by 22
Kim, C.-L., Shin, Y.-S., Choi, S.-H., Oh, S., Kim, K., Jeong, H.-S., & Mo, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5619761 · Cited by 20
“Phosphorylation of Ser909 and /r1079 is essential for LATS1 kinase activity [35].”
BackgroundUnraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ–CAMTA1 Fusion Driven Sarcoma
Seavey, C. N., Pobbati, A. V., & Rubin, B. (2022) · Cancers · doi:10.3390/cancers14122980 · Cited by 20
“Phosphorylation enhances the interaction between LATS1/2 and MOB1A/MOB1B proteins and leads to the activation of the complex [28,31].”
BackgroundHippo Signaling in the Heart – Non-Canonical Pathways Impact Growth, Survival and Function –
Re, D. P. D. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0426 · Cited by 19
Yang, Y., dos Santos, D. M., Pantano, L., Knipe, R. S., Abe, E. A., Logue, A., Pronzati, G., Black, K. E., Spinney, J. J., Giacona, F. L., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0428oc · Cited by 20
Maerz, S., Dettmann, A., & Seiler, S. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06263-11 · Cited by 20
“Germinal center (GC) kinases, a subfamily of Ste20-type kinases (10, 47), are involved in phosphorylation of this hydrophobic motif (9, 12, 26, 55, 57, 64).”
BackgroundInteraction of non-coding RNAs and Hippo signaling: Implications for tumorigenesis
Liu, C., Wu, Y., & Ma, J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.08.012 · Cited by 20
Mechano-Signaling Aspects of Hepatocellular Carcinoma
Passi, M., & Zahler, S. (2021) · Journal of Cancer · doi:10.7150/jca.60102 · Cited by 23
Ras Family Small GTPase-Mediated Neuroprotective Signaling in Stroke
Shi, G., Andres, D., & Cai, W. (2011) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152411796011349 · Cited by 20
“MST1/2 has also been shown to bind and activate WW45/LATS, which inhibits the mammalian transcriptional activator yes-associated protein (Yap), leading to the downregulation of IAPs, to promote apoptosis [286–289].”
BackgroundWang, R., Li, Y., Hu, E.-Z., Kong, F., Wang, J., Liu, J., Shao, Q., Hao, Y., He, D., & Xiao, X. (2017) · Oncotarget · doi:10.18632/oncotarget.15063 · Cited by 21
“When the Hippo pathway is activated, MST1/2 phosphorylates the hydrophobic motif of LATS1/2 (LATS-HM) and activates LATS1/2 [23], which in turn directly phosphorylate YAP (Yes-associated protein) at serine 127 (YAP-S127) [24, 25, 26, 27].”
BackgroundInfluentialThe Hippo pathway and its correlation with acute kidney injury
Zhang, C., 上海交通大学附属第一人民医院肾内科, 上. 2., Li, C., Xu, K., Zheng, Z., Cheng, G., Wu, H., Liu, J., & 复旦大学基础医学院病理科, 上. 2. (2022) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2022.110 · Cited by 21
“Furthermore, MST1/2-phosphorylated Mps one binder 1 (MOB1) binds to the autoinhibitory domain of LATS1/2, leading to full activation of LATS1/2 (Callus et al., 2006; Chan et al., 2005; Praskova et al., 2004; Wu et al., 2003).”
Emerging Role of YAP and the Hippo Pathway in Prostate Cancer
Koinis, F., Chantzara, E., Samarinas, M., Xagara, A., Kratiras, Z., Leontopoulou, V., & Kotsakis, A. P. (2022) · Biomedicines · doi:10.3390/biomedicines10112834 · Cited by 22
Li, Y., Kong, F., Jin, C., Hu, E.-Z., Shao, Q., Liu, J., He, D., & Xiao, X. (2019) · BMC Cancer · doi:10.1186/s12885-019-5784-0 · Cited by 19
Yagi, H., Onoyama, I., Asanoma, K., Hori, E., Yasunaga, M., Kodama, K., Kijima, M., Ohgami, T., Kaneki, E., Okugawa, K., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901278r · Cited by 18
The LKB1–TSSK1B axis controls YAP phosphorylation to regulate the Hippo–YAP pathway
Kim, C.-L., Lim, S.-B., Choi, S.-H., Kim, D. H., Sim, Y. E., Jo, E.-H., Kim, K., Lee, K., Park, H.-S., Lim, S. B., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06465-4 · Cited by 16
“In conclusion, our fi ndings indicate that TSSK1B inhibits the tumorigenic potential of YAP independently of LATS1/ 2 by phosphorylating YAP at Ser94, as demonstrated in in vitro colony forming assays and in vivo mouse models.”
Chen, G., Gao, J., Wu, S., Chang, Y., Chen, Z., Sun, J., Zhang, L., Wu, J., Sun, X., Quick, W. P., et al. (2024) · The Plant Cell · doi:10.1093/plcell/koae146 · Cited by 16
Hippo circuitry and the redox modulation of hippo components in cancer cell fate decisions
Ashraf, A., & Pervaiz, S. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.10.001 · Cited by 16
The polarity protein Angiomotin p130 controls dendritic spine maturation
Wigerius, M., Quinn, D. P., Diab, A. M., Clattenburg, L., Kolar, A., Qi, J., Krueger, S., & Fawcett, J. P. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201705184 · Cited by 16
“Using an antibody that specifically recognizes phosphorylation of serine 909 in Lats1 (pSer909) as a readout for elevated kinase activity (Chan et al., 2005), we detected major phosphorylation in the embryonic and P1 stages with drastically lower amounts at P7 and no detectable signal in adult samples (Fig.”
BackgroundSalvador has an extended SARAH domain that mediates binding to Hippo kinase
Cairns, L. S., Tran, T. T., Fowl, B. H., Patterson, A., Kim, Y. J., Bothner, B. B., & Kavran, J. M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000923 · Cited by 16
de Amorim, Í. S. S., Rodrigues, M. M. D. S., & Mencalha, A. L. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03552-3 · Cited by 16
Baldan, S., Meriin, A. B., Yaglom, J. A., Alexandrov, I. M., Varelas, X., Xiao, Z. J., & Sherman, M. Y. (2021) · Journal of Cell Science · doi:10.1242/jcs.259107 · Cited by 18
Liao, H.-Y., Da, C.-M., Wu, Z., & Zhang, H. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.10.015 · Cited by 18
Cell Cycle Regulated Interaction of a Yeast Hippo Kinase and Its Activator MO25/Hym1
Hsu, J. Y., & Weiss, E. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078334 · Cited by 16
“specifically phosphorylate the HM site of an NDR kinase [9,12],”
BackgroundPoly(rC)-Binding Protein 2 Regulates Hippo Signaling To Control Growth in Breast Epithelial Cells
Li, F., Zumbrennen‐Bullough, K. B., Vashisht, A. A., Wohlschlegel, J. A., & Philpott, C. C. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00104-16 · Cited by 16
“Lats1 and Lats2 are downstream kinases in the Hippo pathway that can be phosphorylated by the Sav1-Mst1/Mst2 complex (28).”
BackgroundThe role of Hippo signaling pathway in physiological cardiac hypertrophy
Gholipour, M., & Tabrizi, A. (2019) · Bioimpacts · doi:10.34172/bi.2020.32 · Cited by 16
Advances in Understanding the LncRNA-Mediated Regulation of the Hippo Pathway in Cancer
Wang, M., Xu, T., Feng, W.-Y., Liu, J., & Wang, Z. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s283157 · Cited by 16
Virdi, J. K., & Pethe, P. S. (2022) · Cytotechnology · doi:10.1007/s10616-022-00537-z · Cited by 15
Dubois, F., Bazille, C., Levallet, J., Maille, E., Brosseau, S., Madelaine, J., Bergot, E., Zalcman, G., & Levallet, G. (2022) · Targeted Oncology · doi:10.1007/s11523-022-00900-2 · Cited by 18
“Each kinase displays two main regulatory sites, including an activation loop where the serine residues 909 and 841 are harbored, in addition to a phosphorylation site by MST kinases on threonine 1079 and 1041 [204] (Fig.”
BackgroundThe role of YAP in the control of the metastatic potential of oral cancer
Ahmad, U. S., SARAVANAN, K., & Wan, H. (2021) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2022.026085 · Cited by 18
Hippo Signaling in Mitosis: An Updated View in Light of the MEN Pathway
Hergovich, A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6502-1_19 · Cited by 15
Yang, Z., & Joyner, A. L. (2019) · Developmental Biology · doi:10.1016/j.ydbio.2019.07.018 · Cited by 16
HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14
Blakely, W. J., Hatterschide, J., & White, E. A. (2024) · mBio · doi:10.1128/mbio.01811-24 · Cited by 15
“SAV1 promotes MST1 binding to LATS1 and MOB1A/B promotes LATS1 binding to YAP1 (41, 46–49).”
BackgroundZhang, S., Chen, L., Shan, Y., Sui, Z., Wu, Q., Zhang, L., Liang, Z., & Zhang, Y. (2016) · The Analyst · doi:10.1039/c6an00388e · Cited by 14
Metadata
- Authors
- Chan, E. H. Y., Nousiainen, M., Chalamalasetty, R. B., Schäfer, A., Nigg, E. A., & Silljé, H. H. W.
- Affiliations
- Max Planck Society (DE)
- Corresponding author
- Silljé, Herman H W
- Venue
- Oncogene
- Published
- 2005-01-31
- Volume
- 24
- Issue
- 12
- Pages
- 2076-2086
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2105193974
- Cited by
- 584
- References
- 42
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 41 · 2023: 19 · 2022: 37 · 2021: 39 · 2020: 40 · 2019: 36 · 2018: 39 · 2017: 26 · 2016: 36 · 2015: 35 · 2014: 22 · 2013: 29 · 2012: 24
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- Croucher Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- MST2, LATS1, LATS2, Ste20-like kinase, Hippo signaling pathway, Warts kinase, kinase activation, phosphorylation sites, catalytic domain, tumor suppressor kinase, cell cycle regulation, apoptosis
- MeSH terms
- Serine-Threonine Kinase 3, Hippo Kinases, Amino Acid Sequence, Animals, Cell Line, Drosophila melanogaster, Gene Expression Regulation, HeLa Cells, Humans, Kidney, Peptide Fragments, Genes, Tumor Suppressor, Protein Serine-Threonine Kinases, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Tumor Suppressor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.